Substance Use Disorders Overview

Principles

Definition

Substance use disorders is an interdisciplinary research field dedicated to investigating the complex biological, psychological, and social factors underlying problematic substance use, its clinical presentation, and the development of effective prevention and intervention strategies. It serves as a critical area of study for understanding addiction and improving public health.

Ontological type

Treatment Modalities

Diagnostic Frameworks

Etiology Models

Key developments

Key Figures

Medicalization and Pharmacotherapy era

Tim Stockwell [1], affiliated with University of Exeter [3] and University of Surrey [4] during the Medicalization and Pharmacotherapy era, contributed to standardized assessment approaches. His key contribution is the development and validation of The Severity of Alcohol Dependence Questionnaire: Its Use, Reliability and Validity [7], a standardized assessment tool that underpinned diagnosis, outcome tracking, and relapse prediction, crucial for the era's measurement infrastructure. Donald W. Goodwin [2], affiliated with Washington University in St. Louis [5] and University of Iowa [6] during this era, contributed to a longitudinal perspective on alcoholism. His 1984 paper The Natural History of Alcoholism: Causes, Patterns, and Paths to Recovery [8] offered a longitudinal view of causes and trajectories and highlighted implications for pharmacotherapy and clinical management, reinforcing the medicalization approach.

Comorbidity-Driven Integrated Care era

John B. Saunders [1], with affiliations including Stanford University [3] and Brisbane School of Theology [4], was a central figure in advancing comorbidity-driven integrated care during 1988-2001. Saunders [1] contributed to key changes through the AUDIT guidelines for primary care [7], which helped standardize screening for alcohol use disorders and support treatment matching in co-occurring conditions. Thomas F. Babor [2], with ties to Yale University [5] and the University of Wisconsin–Madison [6], was another leading advocate for structured screening and subtype identification within this era. His contribution, jointly expressed in the AUDIT guidelines [7], strengthened reliability-focused measurement and informed patient-treatment fit for dual-diagnosis populations, aligning with the era's emphasis on individualized, chronic-care approaches.

Implementation and Scale-Up era

Bridget F. Grant [1] is a central figure in the Implementation and Scale-Up era, with affiliations including the University of California, San Francisco [3] and Yale University [4]. Grant [1] identified key contributions such as detailing the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders [6], establishing the reliability of AUDADIS-IV for measuring alcohol use, tobacco use, and psychiatric modules in a general population sample [7], and analyzing sociodemographic predictors of first incidence of DSM-IV disorders [8], which underpinned surveillance efforts and resource planning in this era. Frederick S. Stinson [2] anchors this era's epidemiologic expansion from Columbia University [5], contributing to national survey-driven work that relied on findings [6], reliability assessments [7], and predictor analyses [8], essential for scalable surveillance and policy prioritization. Stinson [2] and his Columbia affiliation [5] further shaped implementation by interpreting prevalence and comorbidity results [6], validating diagnostic instruments [7], and modeling first-incidence predictors [8], guiding cascade-of-care and primary-care integration strategies during scale-up.